Biogen Inc. (NASDAQ:BIIB) Q2 2020 Results Earnings Conference Call July 22, 2020 8:00 AM ET
Company Participants
Joe Mara - Vice President, Investor Relations
Michel Vounatsos - Chief Executive Officer
Alfred Sandrock, Jr. - Executive Vice President, Research & Development and Chief Medical Officer
Jeffrey Capello - Executive Vice President and Chief Financial Officer
Conference Call Participants
Cory Kasimov - JPMorgan
Geoff Meacham - Bank of America
Umer Raffat - Evercore
Marc Goodman - SVB Leerink
Jay Olson - Oppenheimer
Michael Yee - Jefferies
Terence Flynn - Goldman Sachs
Matthew Harrison - Morgan Stanley
Ronny Gal - Bernstein
Phil Nadeau - Cowen and Company
Tim Anderson - Wolfe Research
Brian Abrahams - RBC Capital
Evan Seigerman - Credit Suisse
Robyn Karnauskas - SunTrust Robinson Humphrey
Operator
Good morning. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Second Quarter 2020 Financial Results and Business Update. All lines have been placed on mute to prevent any background noise. After the speakers remarks there will be a question-and-answer session. [Operator Instructions] Thank you.
I would now like to turn the conference over to Mr. Joe Mara, Vice President, Investor Relations. You may begin your conference.
Joe Mara
Good morning, and welcome to Biogen's second quarter 2020 earnings call. Before we begin, I encourage everyone to go to the Investors section of biogen.com to find the earnings release and related financial tables, including a reconciliation of the GAAP to non-GAAP financial measures that we will discuss today. Our GAAP financials are provided in Tables 1 and 2, and Table 3 includes a reconciliation of our GAAP to non-GAAP financial results and our GAAP to non-GAAP financial guidance. We believe non-GAAP financial results better represent the ongoing economics of our business and reflect how we manage
- Read more current BIIB analysis and news
- View all earnings call transcripts